| Title |
|
|
|
Antimicrobial drug use and macrolide-resistant **Streptococcus pyogenes**, Belgium
| |
| Author |
|
|
|
| |
| Abstract |
|
|
|
| In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 19972007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 19992009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs. | | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Emerging infectious diseases / National Center for Infectious Diseases. Centers for Disease Control and Prevention. - Atlanta, Ga | |
| Publication |
|
|
|
Atlanta, Ga : 2012
| |
| ISSN |
|
|
|
1080-6040
| |
| Volume/pages |
|
|
|
18:9(2012), p. 1515-1518
| |
| ISI |
|
|
|
000307989700024
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
| | |
|